Smith Group Asset Management’s Clovis Oncology, Inc. CLVS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-1,270
| Closed | -$19K | – | 457 |
|
|
2019
Q2 | $19K | Hold |
1,270
| – | – | ﹤0.01% | 335 |
|
|
2019
Q1 | $32K | Sell |
1,270
-4,400
| -78% | -$111K | ﹤0.01% | 338 |
|
|
2018
Q4 | $102K | Sell |
5,670
-500
| -8% | -$9K | ﹤0.01% | 281 |
|
|
2018
Q3 | $181K | Buy |
6,170
+1,620
| +36% | +$47.5K | 0.01% | 253 |
|
|
2018
Q2 | $207K | Buy |
4,550
+100
| +2% | +$4.55K | 0.01% | 250 |
|
|
2018
Q1 | $235K | Sell |
4,450
-3,600
| -45% | -$190K | 0.01% | 238 |
|
|
2017
Q4 | $547K | Hold |
8,050
| – | – | 0.02% | 202 |
|
|
2017
Q3 | $663K | Hold |
8,050
| – | – | 0.02% | 193 |
|
|
2017
Q2 | $754K | Buy |
8,050
+1,210
| +18% | +$113K | 0.02% | 175 |
|
|
2017
Q1 | $436K | Hold |
6,840
| – | – | 0.01% | 196 |
|
|
2016
Q4 | $304K | Buy |
+6,840
| New | +$304K | 0.01% | 222 |
|
|
2015
Q4 | – | Sell |
-8,030
| Closed | -$738K | – | 521 |
|
|
2015
Q3 | $738K | Sell |
8,030
-51
| -0.6% | -$4.69K | 0.03% | 182 |
|
|
2015
Q2 | $706K | Buy |
+8,081
| New | +$706K | 0.02% | 184 |
|